The Latest in FDA Evaluations and Research

FDA News


Latest News from FDA News
NEW YORK, Aug. 29, 2014 /PRNewswire/ -- As power morcellator lawsuit (http://www.gynecaremorcellatorlawsuit.com/) filings continue to mount in U.S. courts, Bernstein Liebhard LLP notes that one medical device manufacturer is taking issue with a doctor who is working to have uterine mor...
In the news release "Green Innovations Promotes Jeff Thurgood to CEO," we are advised by the company that various information in the press release (found in paragraphs 2, 3, 4, 7, and 9) has changed. Complete corrected text follows.
PISCATAWAY, N.J., Aug. 29, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s DACOGEN®.  InnoPharma developed...
RARITAN, N.J., Aug. 29, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO® (rivaroxaban) to include additional high-risk ...
CHICAGO, Aug. 29, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the JPMor...
NEW YORK, August 29, 2014 /PRNewswire/ --
Green Innovations Ltd. (OTCQB: GNIN) (OTCBB: GNIN) today announced it has promoted Jeff Thurgood, Vice President - Sales, to Chief Executive Officer.
NEW YORK, Aug. 28, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:Needle-Free Delivery: Technology and Market Forecast 2014-2024 http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-20...
NEW YORK and POINT ROBERTS, Washington, August 28, 2014 /PRNewswire/ --
TORONTO, Aug. 28, 2014 /PRNewswire-iReach/ -- Sciedu Press is a scientific publishing house and completely private. They publish various researches from around the globe in the fields of education, science, and culture, which include educational and scientific books along with scholarl...
DENVER, Aug. 28, 2014 /PRNewswire/ -- Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials.   
SANTA MONICA, Calif., Aug. 28, 2014 /PRNewswire/ -- In anticipation of the upcoming MEDevice San Diego event, a new infographic is being made available for the first time. Industry Overview: Medtech & Life Sciences in San Diego offers a snapshot of San Diego's critical involvement ...
NEW YORK, Aug. 28, 2014 /PRNewswire/ -- UPMC Health Plan has become the latest insurer to end coverage of uterine morcellation in light of the cancer risks associated with power morcellators (http://www.injurybeacon.com/power-morcellator/), Bernstein Liebhard LLP reports. In a statemen...
PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product...
ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD.
CAMBRIDGE, Mass., Aug. 28, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, announced today that Dr. David Cook, Seres' Executive Vice President of R&D and Chief Scientific Officer, wi...
DETROIT, Aug. 28, 2014 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in collaboration with Wayne State University School of Medicine (WSU SOM), will present the fourth annual Prostate Cancer Symposium, Latest Treatment Advancements: What you learn here could sav...
NEW YORK, August 28, 2014 /PRNewswire/ --
CASTLE ROCK, Colo., Aug. 28, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid blood test for aiding in identifying children, adolescent, and young adult patien...
THOUSAND OAKS, Calif., Aug. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 YUKAWA-2 (StudY of LDL-Cholesterol Reduction Using a Monoclonal PCSK9 Antibody in Japanese Patients With Advanced Cardiovascular Risk) study evaluating evolocumab in combination wi...
MONTREAL and SAN CLEMENTE, Calif., Aug. 28, 2014 /PRNewswire/ -- ReShape Medical® today announced that positive data in support of the ReShape™ Integrated Dual Balloon System will be highlighted at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 2...
THOUSAND OAKS, Calif., Aug. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for evolocumab seeking approval for the treatment of high cholesterol. Evolocumab is an inves...
XPRIZE, el líder mundial en competencias incentivadas con premios, anunció hoy a los 10 equipos finalistas que compiten por los 10 millones de USD de Qualcomm Tricorder XPRIZE, una competencia global de 3 años y medio patrocinada por Qualcomm Foundati...
XPRIZE, der weltweite Marktführer bei Incentive-Wettbewerben, hat heute die 10 führenden Teams bekannt gegeben, die um den 10 Miollionen US-Dollar schweren Qualcomm Tricorder XPRIZE konkurrieren, ein 3,5-jähriger weltweiter Wettbewerb, gesponsert von ...
HOUSTON, Aug. 28, 2014 /PRNewswire/ -- EMIT Corporation announced today that it has received CE-Mark for its HypothermX® Intravenous Fluid and Blood Warming Devices with sterile fluid paths, allowing for sales expansion into the European and other OUS markets.  EMIT Corporation also an...
Atossa Genetics Inc. (NASDAQ: ATOS) today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc., or the NRLBH, has entered into an agreement with BioVentive, Inc. for the marketing and promotion of the NRLBH's laboratory services. The NRLBH is a CLIA-...
ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm)...
MENLO PARK, Calif., Aug. 28, 2014 /PRNewswire/ -- Armetheon, Inc. (www.armetheon.com), a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing. The Series ...
Miraculins Inc. (TSX VENTURE: MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, has announced its plans to file pre-submission documentation...
Miraculins Inc. (TSX VENTURE:MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, has announced its plans to file pre-submission documentation ...
CHESTERBROOK, Pa., Aug. 28, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data from trials evaluating the use of collagenase clostridium histolyticum (CCH) for treating two Dupuytren's contracture (DC) co...
A XPRIZE, líder global em competições de prêmios incentivados, anunciou hoje as dez equipes finalistas concorrentes para o prêmio Qualcomm Tricorder XPRIZE de US$ 10 milhões, uma competição global de três anos e meio, patrocinada pela Fundação Qualcom...
XPRIZE, le leader mondial des compétitions dotées d’incitations financières, a annoncé aujourd’hui les 10 équipes finalistes pour « $10 M Qualcomm Tricorder XPRIZE », une compétition mondiale se déroulant sur trois ans et demi, parrainée par la Fondat...
Informieren Sie sich über die wirksame Nutzung, Analyse und besten Praktiken der Erfassung von eCOA-Daten in Onkologieprogrammen in einem neuen Schulungswebinar am 10. September. Das Webinar wird von der PHT Corporation, dem führenden Anbieter von Tec...
Découvrez l'utilisation efficace, l'analyse et les pratiques d'excellence concernant la collecte de données eCOA dans le cadre de programmes d'oncologie lors d'un nouveau séminaire éducatif en ligne, le 10 septembre. Le séminaire en ligne est organisé...
TAIPEI, Aug. 27, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc. (4180.TT) today announced that it has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for megestrol acetate 125mg/ml oral suspension, the gen...
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), dedicated to the early detection of skin cancer, announced its results for the three and six months ended June 30, 2014, which are also available on SEDAR (www.sedar.com).
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX), dedicated to the early detection of skin cancer, announced its results for the three and six months ended June 30, 2014, which are also available on SEDAR (www.sedar.com).